journal
https://read.qxmd.com/read/39236985/deep-learning-assisted-interactive-contouring-of-lung-cancer-impact-on-contouring-time-and-consistency
#1
JOURNAL ARTICLE
Michael J Trimpl, Sorcha Campbell, Niki Panakis, Daniel Ajzensztejn, Emma Burke, Shawn Ellis, Philippa Johnstone, Emma Doyle, Rebecca Towers, Geoffrey Higgins, Claire Bernard, Roland Hustinx, Katherine A Vallis, Eleanor P J Stride, Mark J Gooding
BACKGROUND AND PURPOSE: To evaluate the impact of a deep learning (DL)-assisted interactive contouring tool on inter-observer variability and the time taken to complete tumour contouring. MATERIALS AND METHODS: Nine clinicians contoured the gross tumour volume (GTV) using the PET-CT scans of 10 non-small cell lung cancer (NSCLC) patients, either using DL-assisted or manual contouring tools. After contouring a case using one contouring method, the same case was contoured one week later using the other method...
September 3, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39236984/impact-of-mediastinal-tumor-burden-and-lymphatic-spread-in-locally-advanced-non-small-cell-lung-cancer-a-secondary-analysis-of-the-multicenter-randomized-pet-plan-trial
#2
JOURNAL ARTICLE
Eleni Gkika, Cas Stefaan Dejonckheere, Jörg Sahlmann, Simeon Ari Barth, Tanja Schimek-Jasch, Sonja Adebahr, Markus Hecht, Matthias Miederer, Alexander Brose, Harald Binder, Jochem König, Anca-Ligia Grosu, Ursula Nestle, Andreas Rimner
PURPOSE: The aim of this secondary analysis of the prospective randomized phase 2 PET-Plan trial (ARO-2009-09; NCT00697333) was to evaluate the impact of mediastinal tumor burden and lymphatic spread in patients with locally advanced non-small-cell lung cancer (NSCLC). METHODS: All patients treated per protocol (n = 172) were included. Patients received isotoxically dose-escalated chemoradiotherapy up to a total dose of 60-74 Gy in 30-37 fractions, aiming as high as possible while adhering to normal tissue constraints...
September 3, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39227287/call-for-papers-radiotherapy-oncology-and-the-lancet-oncology-collaboration
#3
EDITORIAL
Pierre Blanchard, David Collingridge
No abstract text is available yet for this article.
September 2, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39222849/pretreatment-plasma-osteopontin-level-as-a-marker-of-response-to-curative-radiotherapy-and-hormonal-treatment-for-prostate-cancer
#4
JOURNAL ARTICLE
Beata Smolska-Ciszewska, Jolanta Mrochem-Kwarciak, Katarzyna Karczmarczyk, Regina Deja, Rafał Suwiński
BACKGROUND AND PURPOSE: Osteopontin is a known marker for tumour hypoxia with relevance for the outcome of radiotherapy. We analysed the plasma concentration of OPN in prostate cancer patients receiving RT with or without ADT to evaluate OPN as a potential marker of treatment response. MATERIALS AND METHODS: Between 2012 and 2014, 274 patients with prostate cancer qualifying for RT were enrolled to the study. SCADT received 34.3 % of patients, LCADT 46.3 %...
August 31, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39222848/fully-automated-radiotherapy-treatment-planning-a-scan-to-plan-challenge
#5
JOURNAL ARTICLE
Mark J Gooding, Shafak Aluwini, Teresa Guerrero Urbano, Yasmin McQuinlan, Deborah Om, Floor H E Staal, Tanguy Perennec, Sana Azzarouali, Carlos E Cardenas, Antony Carver, Stine Sofia Korreman, Jean-Emmanuel Bibault
BACKGROUND AND PURPOSE: Over the past decade, tools for automation of various sub-tasks in radiotherapy planning have been introduced, such as auto-contouring and auto-planning. The purpose of this study was to benchmark what degree of automation is possible. MATERIALS AND METHODS: A challenge to perform automated treatment planning for prostate and prostate bed radiotherapy was set up. Participants were provided with simulation CTs and a treatment prescription and were asked to use automated tools to produce a deliverable radiotherapy treatment plan with as little human intervention as possible...
August 31, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39222847/deep-learning-for-contour-quality-assurance-for-rtog-0933-in-silico-evaluation
#6
JOURNAL ARTICLE
Evan M Porter, Charles Vu, Ina M Sala, Thomas Guerrero, Zaid A Siddiqui
PURPOSE: To validate a CT-based deep learning (DL) hippocampal segmentation model trained on a single-institutional dataset and explore its utility for multi-institutional contour quality assurance (QA). METHODS: A DL model was trained to contour hippocampi from a dataset generated by an institutional observer (IO) contouring on brain MRIs from a single-institution cohort. The model was then evaluated on the RTOG 0933 dataset by comparing the treating physician (TP) contours to blinded IO and DL contours using Dice and Haussdorf distance (HD) agreement metrics as well as evaluating differences in dose to hippocampi when TP vs...
August 31, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39218041/single-preoperative-radiation-therapy-with-delayed-surgery-for-low-risk-breast-cancer-oncologic-outcome-toxicity-and-cosmesis-of-the-sport-ds-phase-i-trial
#7
JOURNAL ARTICLE
Danny Lavigne, Tarek Hijal, Peter Vavassis, Marie-Christine Guilbert, Lucas Sideris, Pierre Dubé, Mai-Kim Gervais, Guy Leblanc, Michel-Pierre Dufresne, David Nguyen, David Tiberi, Dima Mahmoud, Michael Yassa
BACKGROUND: A novel approach using single-fraction preoperative partial breast irradiation (PBI) for low-risk breast cancer is under study. We sought to investigate the rate of pathologic response (pR), toxicities and cosmetic results related to this new treatment strategy. METHODS: Women of 65 years or older with stage I unifocal luminal A breast cancer were eligible for inclusion in this phase I prospective trial. Patients received a single 20 Gy dose of PBI followed by breast-conserving surgery (BCS) 3 months later...
August 30, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39218040/single-pre-operative-radiation-therapy-sport-ck-trial-for-low-risk-breast-cancer-early-results-of-a-phase-2-study
#8
JOURNAL ARTICLE
Dima Mahmoud, Michael Yassa, Leticia Alvarado, Christine Lambert, Sarkis Meterissian, Dawn Anderson, Francine Tremblay, Naim Otaky, John Keyserlingk, Valerie Panet-Raymond, Neil Kopek, Marc David, Marie Duclos, Catherine Pembroke, David Fleiszer, Ari N Meguerditchian, Antoine Loutfi, Danny Lavigne, Tarek Hijal
BACKGROUND AND PURPOSE: Preoperative partial breast irradiation (PBI) is a novel technique that can be used in patients with early-stage breast cancer with the goal of limiting the irradiated breast volume, toxicity and number of fractions. The aim of this trial is to assess the toxicity, surgical, oncologic and cosmetic outcomes of preoperative PBI. MATERIALS AND METHODS: In this single-arm phase II trial, we enrolled women ≥ 60 years, with unifocal low-risk breast invasive ductal carcinoma (cT1N0, grade 1-2, ER+, Her2-)...
August 30, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39218039/survival-after-neoadjuvant-chemotherapy-or-chemoradiotherapy-for-resectable-esophageal-squamous-cell-carcinoma-a-pooled-analysis-of-randomized-clinical-trials
#9
JOURNAL ARTICLE
Yang Yang, Rongjun Shao, Xiufeng Cao, Mengyuan Chen, Wangang Gong, Hangjie Ying, Ge Song, Guangxian You, Guoqin Qiu, Qixun Chen, Yongling Ji, Dong Xu
BACKGROUND: The comparison of neoadjuvant chemoradiotherapy (nCRT) versus neoadjuvant chemotherapy (nCT) for locally advanced esophageal squamous cell carcinoma (ESCC) remains inconclusive, and the optimal regimen is still under investigation. METHODS: Prospective randomized clinical trials were systematically searched in electronic databases from inception to Oct 2023. A graphical reconstructive algorithm was employed to extract time-to-event outcomes from Kaplan-Meier curves presented in the original studies...
August 30, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39216826/clinical-target-volume-design-and-dose-in-carbon-ion-radiation-therapy-for-sinonasal-mucosal-melanoma
#10
JOURNAL ARTICLE
Wan-Chin Yang, Masashi Koto, Hiroaki Ikawa, Reiko Imai, Makoto Shinoto, Hirotoshi Takiyama, Tetsuro Isozaki, Shigeru Yamada
BACKGROUND AND PURPOSE: No guidelines exist for the clinical target volume (CTV) and radiotherapy dose in sinonasal mucosal melanoma (SNMM). Thus, we aimed to determine the carbon-ion radiotherapy (CIRT) CTV and dose for SNMM. MATERIALS AND METHODS: In total, 135 patients with SNMM who received CIRT were reviewed. The relative biological effectiveness-weighted dose was 57.6 or 64 Gy in 16 fractions. CTV was classified into small CTV, which included the gross tumor and visible melanosis within a certain margin, and extended CTV, which included the tumor site and adjacent anatomical structures...
August 29, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39216825/post-hoc-analysis-of-clinicopathological-factors-affecting-lateral-lymph-node-metastasis-based-on-stellar-study-for-rectal-cancer
#11
JOURNAL ARTICLE
Li-Ning Chen, Jun Jiang, Li-Ming Jiang, Hai-Tao Zhou, Ning Li, Ning-Ning Lu, Yuan-Hong Gao, Shi-Xin Liu, Wen-Ling Wang, Li-Chun Wei, Shuai Li, Yong Cai, Yong-Heng Li, Shu-Lian Wang, Yue-Ping Liu, Yong-Wen Song, Hui Fang, Bo Chen, Ye-Xiong Li, Jing Jin, Yuan Tang
PURPOSE: In post-hoc analyses of phaseIII randomized controlled study(STELLAR), to analyzethe prognostic impact oflateral pelvic lymph node (LPLN)metastasis in locally advanced rectal cancer (LARC). METHODS: LPLN metastasis was defined as a short diameter > 7 mm on magnetic resonance imaging (MRI).The studyincluded 591 patients with LARC.All patients received neoadjuvant (chemo)radiotherapy combined withradical resection. RESULTS: Among 591 patients, 99 (16...
August 29, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39216824/risk-factors-for-recurrent-laryngeal-nerve-injury-in-microwave-ablation-of-thyroid-nodules-a-multicenter-study
#12
JOURNAL ARTICLE
Ming-Hong Xu, Jian-Ping Dou, Mo-Han Guo, Wen-Qi Yi, Zhi-Yu Han, Fang-Yi Liu, Jie Yu, Zhi-Gang Cheng, Xiao-Ling Yu, Hui Wang, Nan Bai, Shu-Rong Wang, Ming-An Yu, Ping Liang, Lei Chen
BACKGROUND AND PURPOSE: This study aimed to investigate the risk factors for recurrent laryngeal nerve (RLN) injury after microwave ablation (MWA) of thyroid nodules and to identify factors influencing the recovery time of post-procedure hoarseness. MATERIALS AND METHODS: We retrospectively analyzed data from patients who underwent MWA for thyroid nodules at five hospitals between November 2018 and July 2022. Patients were divided into malignant and benign nodule groups...
August 29, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39214256/robust-localization-of-poorly-visible-tumor-in-fiducial-free-stereotactic-body-radiation-therapy
#13
JOURNAL ARTICLE
Di Xu, Martina Descovich, Hengjie Liu, Ke Sheng
BACKGROUND AND PURPOSE: Effective respiratory motion management reduces healthy tissue toxicity and ensures sufficient dose delivery to lung cancer cells in pulmonary stereotactic body radiation therapy (SBRT) with high fractional doses. An articulated robotic arm paired with an X-ray imaging system is designed for real-time motion-tracking (RTMT) dose delivery. However, small tumors (<15 mm) or tumors at challenging locations may not be visible in the X-ray images, disqualifying patients with such tumors from RTMT dose delivery unless fiducials are implanted via an invasive procedure...
August 28, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39197502/daily-cbct-based-dose-calculations-for-enhancing-the-safety-of-dose-escalation-in-lung-cancer-radiotherapy
#14
JOURNAL ARTICLE
S N Thomsen, D S Møller, M M Knap, A A Khalil, T Shcytte, L Hoffmann
PURPOSE: Dose-escalation in lung cancer comes with a high risk of severe toxicity. This study aimed to calculate the delivered dose in a Scandinavian phase-III dose-escalation trial. METHODS: The delivered dose was evaluated for 21 locally-advanced non-small cell lung cancer (LA-NSCLC) patients treated as part of the NARLAL2 dose-escalation trial. The patients were randomized between standard and escalated heterogeneous dose-delivery. Both treatment plans were created and approved before randomization...
August 26, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39197501/stereotactic-ablative-radiotherapy-for-oligoprogressive-solid-tumours-a-systematic-review-and-meta-analysis
#15
REVIEW
Vivian S Tan, Jerusha Padayachee, George B Rodrigues, Inmaculada Navarro, Prakesh S Shah, David A Palma, Aisling Barry, Rouhi Fazelzad, Jacques Raphael, Joelle Helou
INTRODUCTION: The aim of this systematic review and meta-analysis was to review evidence and pool outcomes to assess the effectiveness of stereotactic ablative radiotherapy (SABR) in patients treated for oligoprogressive metastases. METHODS AND MATERIALS: A search was conducted January 2010 to January 2023 in five bibliographic databases for studies of patients with oligoprogressive disease treated with SABR to all lesions. Clinical outcomes included PFS (progression free survival), OS (overall survival) and CST (change to next-line systemic therapy)...
August 26, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39197500/management-of-post-radiation-carotid-blowout-syndrome-in-patients-with-head-and-neck-cancer-a-systematic-review
#16
REVIEW
Wang-Yong Zhu, Jiang Huang, Zhao-Qun Lu, Siyi Yang, Guan Huang, Li-Wei Zhou, Gary Shun Pan Cheung, Jimmy Yu-Wai Chan, Ping-An Wu
BACKGROUND AND PURPOSE: Carotid blowout syndrome (CBS) is a rare but potentially life-threatening complication that can occur in patients with head and neck cancer (HNC), especially with a history of radiotherapy. This study aimed to review and initially compare managements for post-radiation CBS in patients with HNC. MATERIALS AND METHODS: A systematic review of published studies was performed. Information including management, survival, and complication were collected...
August 26, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39191302/assessment-of-integrated-electromagnetic-tracking-for-dwell-position-monitoring-in-a-clinical-hdr-brachytherapy-setting-for-prostate-cancer
#17
JOURNAL ARTICLE
Ioannis Androulakis, Jeremy Schiphof-Godart, Laura E van Heerden, Lorne Luthart, René Rijnsdorp, Mischa S Hoogeman, Henrike Westerveld, Miranda E M C Christianen, Jan Willem M Mens, Rosemarijn van Paassen, Eva M Negenman, Remi A Nout, Inger Karine K Kolkman-Deurloo
BACKGROUND: Electromagnetic Tracking (EMT) technology has been integrated in a prototype high-dose-rate brachytherapy (HDR-BT) afterloading device. Its potential for dwell position (DP) monitoring has earlier been demonstrated in prostate phantoms. However, its performance for prostate BT in the clinical setting remains to be assessed. AIM: Assess the reliability and value of EMT measurements in transrectal ultrasound-based (TRUS-based) and computed tomography-based (CT-based) prostate HDR-BT...
August 25, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39191301/induction-plus-concurrent-chemoradiotherapy-versus-concurrent-chemoradiotherapy-in-elderly-patients-with-locoregionally-advanced-nasopharyngeal-carcinoma
#18
JOURNAL ARTICLE
Lin Chen, Hui Wang, Weiqiong Chen, Kunpeng Li, Qingjie Li, Pengjie Ji, Chenglong Huang, Linglong Tang
BACKGROUND: The effectiveness and safety of induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CCRT) in elderly patients with locoregionally advanced nasopharyngeal carcinomas (LANPCs) remain subjects of debate. This study evaluated the efficacy of IC+CCRT compared to CCRT alone in elderly LANPC patients. MATERIALS AND METHODS: This retrospective, single-center study analyzed 335 elderly patients diagnosed with stage III or IVa NPC who received CCRT with or without IC between 2010 and 2016...
August 25, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39186982/mitotam-induces-ferroptosis-and-increases-radiosensitivity-in-head-and-neck-cancer-cells
#19
JOURNAL ARTICLE
F V Reinema, N Hudson, G J Adema, W J M Peeters, J Neuzil, J Stursa, L Werner, F C G J Sweep, J Bussink, P N Span
BACKGROUND AND PURPOSE: Radiotherapy (RT) is an integral treatment part for patients with head and neck squamous cell carcinoma (HNSCC), but radioresistance remains a major issue. Here, we use MitoTam, a mitochondrially targeted analogue of tamoxifen, which we aim to stimulate ferroptotic cell death with, and sensitize radioresistant cells to RT. MATERIALS AND METHODS: We assessed viability, reactive oxygen species (ROS) production, disruption of mitochondrial membrane potential, and lipid peroxidation in radiosensitive (UT-SCC-40) and radioresistant (UT-SCC-5) HNSCC cells following MitoTam treatment...
August 24, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/39182582/evaluating-coronary-arteries-and-predicting-maces-using-ccta-in-lung-cancer-patients-receiving-chemotherapy-or-chemoradiotherapy
#20
JOURNAL ARTICLE
Yuhang Xie, Hesong Shen, Qian Xu, Chunrong Tu, Rui Yang, Tao Liu, Hao Tang, Zhiming Miao, Jiuquan Zhang
BACKGROUND: Whether coronary computed-tomography angiography (CCTA) can detect cancer treatment-related impairments of coronary artery and predict major adverse cardiovascular events (MACEs) in lung cancer patients receiving chemotherapy (CHT) or chemoradiotherapy (CRT) is unclear. OBJECTIVES: This study aimed to evaluate coronary arteries using CCTA parameters and explore the association of these parameters with MACEs in patients with lung cancer receiving CHT or CRT...
August 23, 2024: Radiotherapy and Oncology
journal
journal
20234
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.